Table 2.
Model parameter values for the systems PK/PD model in humans, monkeys, and rabbits
Parameter | Unit | Humans | Monkeys | Rabbits |
---|---|---|---|---|
Physiological parameters | ||||
Body weight | kg | 70 | 3.5 | 2.9 |
Vp | L | 2.6 (Cao et al., 2013) | 0.157 (Zhao et al., 2015) | 0.107 (Armin et al., 1952) |
Visf | L | 15.6 (Cao et al., 2013) | 0.735 (Zhao et al., 2015) | 0.764 (Pavlin et al., 1986) |
Kp | - | 0.4 (Cao et al., 2013) | ||
Vl | L | 5.2 (Cao et al., 2013) | a 0.314 (Zhao et al., 2015) | a 0.153 (Armin et al., 1952) |
L | L·day−1 | 2.904 (Cao et al., 2013) | 0.288 (Zhao et al., 2015) | 0.144 (Zhao et al., 2015) |
σ1 | - | 0.945 (Cao et al., 2013) | ||
σ2 | - | 0.697 (Cao et al., 2013) | ||
σl | - | 0.2 (Cao et al., 2013) | ||
Target parameters | ||||
kon | M−1·s−1 | 4.48×106 (Hilden et al., 2012) | ||
koff | s−1 | b 1.74×10−3 | ||
sTFPI_b | nM | 1.6 (Hansen et al., 2014) | 0.91 (Gu et al., 2017) | 1.4 (Hansen et al., 2014) |
kdegs | day−1 | 1.18 (Farrokhi et al., 2018) | c 2.50 | c 2.62 |
mTFPI_b | nM | b 20.03 | d 11.32 | d 17.50 |
kdegm/kint | day−1 | b 1.155 | c 2.44 | c 2.56 |
Endosome parameters | ||||
CLup | L·day−1 | 1.48 (Yuan et al., 2018) | e 0.045 | e 0.0672 |
krec | day−1 | 124.7 (Hopkins and Trowbridge, 1983) | ||
CLe | L·day−1 | 5.75 (Yuan et al., 2018) | c 0.61 | c 0.53 |
Ve1 | L | f 0.005% of body weight (Li et al., 2014) | ||
Ve2 | L | |||
FcRn_b | nM | 49800 (Shah and Betts, 2012) | ||
k1on | M−1·s−1 | g 2.41×105 | ||
k1off | s−1 | g 0.162 | ||
SC absorption parameters | ||||
F | - | h 0.93 | 0.93 (Agerso et al., 2014) | - |
ka | day−1 | h 0231 | 0.231 (Agerso et al., 2014) | - |
Assume equal to blood volume (Cao et al., 2013);
Optimized in the reduced PK/PD model;
Scaled from human value using a scaling factor of −0.25 for rate constant and 0.75 for clearance based on body weight;
sTFPI and mTFPI are produced through alternative splicing of the same TFPI gene (Maroney et al., 2010). Based on the sTFPI baseline, monkeys and rabbits were calculated as ;
Optimized using PK data of antibodies that show linear clearance (Figure 4);
Assume the volume of endosome is 1% of cell volume and the total endothelial cell volume is 0.5% of total tissue volume (Li et al., 2014);
Assume equal to the binding affinity of adalimumab, a wild-type IgG1, to human FcRn (Suzuki et al., 2010). The IgG isotype has a negligible influence on FcRn binding (Neuber et al., 2014; Vidarsson et al., 2014). Monkey FcRn and rabbit FcRn have been shown to bind human IgG with similar affinity as human FcRn (Szikora et al., 2017; Yeung et al., 2010);
Assume equal to monkey value.